← brief for 2026-10-13 · Slowing decline

Cardiovascular And Renal Benefits of Sodium–Glucose Cotransporter 2 Inhibitors in Patients Without Diabetes: A Review of Current Evidence

Article No results yet Not peer reviewed

Key takeaways

This review looks at how SGLT-2 drugs help the heart and kidneys in people who do not have diabetes. It is a summary of past studies, not a new trial. It suggests these drugs may be useful for a wider group of patients.

Who did this work

Jorge Cano Patiño1, Kenneth Contreras Maldonado2, Jhon Alvarez Molina3, Romario Mendoza-Florez4, Andres Puello Ospina3, Kathy Ortega Perez5, Bleidys Ospino Vides6

Source

Article · OpenAlex, CKD works · 2026-10-12
https://doi.org/10.5281/zenodo.23314088